Publications by authors named "Stephan Henschen"

Claim this Profile
T
Treatment of Classic Mid-Trimester Preterm Premature Rupture of Membranes (PPROM) with Oligo/Anhydramnion between 22 and 26 Weeks of Gestation by Means of Continuous Amnioinfusion: Protocol of a Randomized Multicentric Prospective Controlled TRIAL and Review of the Literature.
Michael Tchirikov, Christian Haiduk, Miriam Tchirikov, Marcus Riemer, Michael Bergner, Stephan Henschen

Life (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER HER2 Primary Breast Cancer.
John F R Robertson, Abigail Evans, Stephan Henschen, Cliona C Kirwan, Ali Jahan

Clin Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
Markus Wallwiener, Naiba Nabieva, Manuel Feisst, Tanja Fehm, Johann de Waal, Stephan Henschen

BMC Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Paul Gaß, Peter A Fasching, Tanja Fehm, Johann de Waal, Mahdi Rezai, Stephan Henschen

Breast Care (Basel)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40).
Gunter von Minckwitz, Silvia Darb-Esfahani, Sibylle Loibl, Jens Huober, Hans Tesch, Stephan Henschen

Breast Cancer Res Treat· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.
Isabell Witzel, Sibylle Loibl, Gunter von Minckwitz, Christoph Mundhenke, Jens Huober, Stephan Henschen

Breast Cancer Res Treat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis